Inspire Medical Systems (NYSE: INSP) reported Q4 EPS of $0.49, $0.55 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $192.5 million versus the consensus estimate of $187.42 million.

GUIDANCE:

Inspire Medical Systems sees FY2024 revenue of $775-785 million, versus the consensus of $779.9 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.